Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation and Depletion: 2015-2020

Historic Depreciation and Depletion for Assembly Biosciences (ASMB) over the last 6 years, with Dec 2020 value amounting to $300,000.

  • Assembly Biosciences' Depreciation and Depletion rose 200.00% to $300,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $600,000, marking a year-over-year increase of 50.00%. This contributed to the annual value of $500,000 for FY2023, which is negligibly% changed negligibly from last year.
  • Per Assembly Biosciences' latest filing, its Depreciation and Depletion stood at $300,000 for Q4 2020, which was up 200.00% from $100,000 recorded in Q3 2020.
  • Over the past 5 years, Assembly Biosciences' Depreciation and Depletion peaked at $300,000 during Q4 2020, and registered a low of $18,000 during Q2 2016.
  • Its 3-year average for Depreciation and Depletion is $133,333, with a median of $100,000 in 2020.
  • In the last 5 years, Assembly Biosciences' Depreciation and Depletion surged by 526.64% in 2018 and then tumbled by 50.00% in 2019.
  • Over the past 5 years, Assembly Biosciences' Depreciation and Depletion (Quarterly) stood at $24,750 in 2016, then soared by 204.34% to $75,324 in 2017, then soared by 32.76% to $100,000 in 2018, then remained steady at $100,000 in 2019, then spiked by 200.00% to $300,000 in 2020.
  • Its Depreciation and Depletion was $300,000 in Q4 2020, compared to $100,000 in Q3 2020 and $100,000 in Q2 2020.